<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to symptoms caused by obstruction in patients with hypertrophic cardiomyopathy*</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to symptoms caused by obstruction in patients with hypertrophic cardiomyopathy*</h1>
<div class="graphic"><div class="figure"><div class="ttl">Approach to symptoms caused by obstruction in patients with hypertrophic cardiomyopathy*</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes"><p>CCB: calcium channel blocker; HCM: hypertrophic cardiomyopathy; LVOT: left ventricular outflow tract gradient.</p>
<p>* In patients with HCM, obstruction is defined as evidence of an LVOT gradient ≥30 mmHg and systolic anterior motion of the mitral valve at rest or with exercise. After starting medical therapy, patients may respond within 6 to 12 months.</p>
<p>¶ We prefer initial treatment with a beta blocker. For patients who cannot tolerate a beta blocker or who do not respond, we typically treat with a nondihydropyridine CCB. For information on doses and titration, refer to UpToDate content on the treatment of patients with obstructive HCM.</p>
<p>Δ The adverse effects and monitoring required for disopyramide and mavacamten therapy are described in UpToDate content on the treatment of obstructive HCM.</p>
◊ Patients who proceed with septal reduction therapy (ie, surgical myectomy, alcohol septal ablation) typically have an LVOT gradient ≥50 mmHg. For the risks and benefits of these therapies, refer to UpToDate content on the treatment of patients with obstructive HCM.</div><div id="graphicVersion">Graphic 140704 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
